EXTON, Pa., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at two investor conferences in November.
Michael Celano, Kensey Nash’s Chief Financial Officer, will deliver the Company’s presentation, at the Oppenheimer 21st Annual Healthcare Conference at the Waldorf Astoria Hotel on Wednesday, November 3rd, 2010 at 2:10 p.m. (ET). To hear the live webcast of the Kensey Nash presentation, go to http://www.veracast.com/webcasts/opco/healthcare2010/38210447.cfm. The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 2:10 p.m. (ET) on Wednesday, November 3rd, 2010.
Joseph W. Kaufmann, Kensey Nash’s President & CEO, will deliver the Company’s presentation, at Sidoti’s Third Annual New York Conference II at the Grand Hyatt Hotel on Tuesday, November 16th, 2010 beginning at approximately at 1:20 p.m. (ET). The presentation materials will also be available on the company’s website (www.kenseynash.com) beginning at 1:20 p.m. (ET) on Tuesday, November 16th, 2010.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
SOURCE Kensey Nash Corporation
